Millions of people experience trauma-related symptoms that fall short of PTSD. 

Ketamine is one of the few medications in psychiatry that reduces suicidal ideation (SI). 

More patients with gender dysphoria (GD) are seeking legal and medical transition. 

Propranolol is commonly used off-label for anxiety, but high-quality data are sparse regarding its use in panic disorder—especially as an SSRI add-on.

SSRIs have been linked to bone thinning and fractures, which matters most for postmenopausal women already at risk. Whether SNRIs carry the same concern has been unclear.

Inflammation is increasingly implicated in OCD. A new randomized trial explores whether a common anti-inflammatory added to standard treatment can meaningfully improve outcomes persistent symptoms.

A decades-old vascular drug unexpectedly lifts mood—offering a fresh angle on treatment-resistant depression.

Long-acting injectables extend stability in bipolar disorder, delaying relapse more effectively than oral antipsychotics

Do SSRIs unmask bipolar disorder in youth? A new Swedish cohort study addresses whether SSRIs trigger mania in children and adolescents with unipolar depression. Learn which risk factors warrant closer monitoring.

Many patients with schizophrenia or recurrent psychotic disorders want to reduce or stop their antipsychotic drugs to minimize adverse effects like sedation, weight gain, and emotional blunting, all of which can impair social functioning.